As drugs move from Ph–I to Ph-II / III, the need for cost efficiency along with speed and quality increases and the incentive to get intermediates manufactured from eastern countries like India increases.

However, tech-transfer and delivery of projects from off-shore locations involves addressing a number of technical and cultural issues and requires intensive monitoring and co-ordination. This intensity can sometimes defeat the economic purpose and also lead to costly delays.

With our team in the UK regularly collaborating with the team in India, we have systematically identified and addressed tech-transfer challenges. Our UK team is responsible for overall delivery to the customer, while ensuring availability of adequate skills and resources on programs in the UK and India.